More Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer PatientsGaya Spolverato, Massimo Rugge, Giacomo Zanus et al.|Frontiers in Oncology|2021Cited by 15
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Chiara Cipollari, Melania Scarpa et al.|Cancer|2024Cited by 8
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Monica Ortenzi, Matteo Fassan et al.|British journal of surgery|2023Cited by 4
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancerGiulia Becherucci, Daunia Verdi, Cesare Ruffolo et al.|Surgery|2024Cited by 2
68 IMMUNOREACT 13: IMMUNE SURVEILLANCE MARKERS IN THE CLINICAL MANAGEMENT OF STAGE II RECTAL CANCERGiorgio Rivella, Marco Scarpa, Melania Scarpa et al.|Gastroenterology|2024Cited by 0